Key Insights

Highlights

Success Rate

86% trial completion

Published Results

29 trials with published results (5%)

Research Maturity

199 completed trials (33% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

5.5%

33 terminated out of 596 trials

Success Rate

85.8%

-0.8% vs benchmark

Late-Stage Pipeline

18%

109 trials in Phase 3/4

Results Transparency

15%

29 of 199 completed with results

Key Signals

29 with results86% success33 terminated

Data Visualizations

Phase Distribution

456Total
Not Applicable (203)
Early P 1 (3)
P 1 (49)
P 2 (92)
P 3 (75)
P 4 (34)

Trial Status

Completed199
Recruiting143
Not Yet Recruiting94
Unknown93
Terminated33
Active Not Recruiting16

Trial Success Rate

85.8%

Benchmark: 86.5%

Based on 199 completed trials

Clinical Trials (597)

Showing 20 of 20 trials
NCT07739160Phase 2Not Yet RecruitingPrimary

The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke Patients

NCT05965687Phase 3CompletedPrimary

Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke (OPENS-3)

NCT05953480Phase 2CompletedPrimary

A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic Stroke

NCT07599904RecruitingPrimary

REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)

NCT05547438Phase 1TerminatedPrimary

Single Ascending Dose Safety and Tolerability of NTS-104 Healthy Adults

NCT07049692Not ApplicableRecruitingPrimary

Hyperbaric Oxygen After Stroke Thrombectomy: A Multicenter Randomized Trial on Safety and Efficacy

NCT06101667Not ApplicableCompletedPrimary

Efficacy and Safety of Endovascular Recanalization for Acute Basilar Artery Occlusion With Extended Time Window (ANGEL-BAO)

NCT07361302Phase 3RecruitingPrimary

A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well

NCT07347665Not ApplicableRecruiting

Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke With Occlusion of the M2 Segment of Middle Cerebral Artery

NCT06638151Phase 2CompletedPrimary

Clopidogrel Plus Aspirin in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPrime)

NCT07013396Not Yet Recruiting

Transcranial Doppler Evaluation After Endovascular Thrombectomy for Acute Ischemic Stroke (PRECISE-TCD)

NCT03346538Phase 2TerminatedPrimary

Dose Finding Study of MCI-186 in Acute Ischemic Stroke

NCT07299994Recruiting

Efficacy and Safety of Intravenous Thrombolysis in Branch Atheromatous Disease

NCT07047326Not ApplicableRecruitingPrimary

Urokinase for Thrombolysis in Acute Ischemic Stroke

NCT05714501Not ApplicableCompletedPrimary

Millipede AspiRation for Revascularization in Stroke (MARRS) Study

NCT07638462Not ApplicableRecruitingPrimary

RIsE Stroke Mobility Study

NCT07693816Recruiting

Early Identification and Diagnosis of BAD-related Stroke

NCT06517173Phase 3CompletedPrimary

Y-3 for Injection in the Treatment of Acute Ischemic Stroke

NCT07687043Not ApplicableCompletedPrimary

Buyang Huanwu Decoction With Wuling Powder for Acute Ischemic Stroke

NCT06485427Not ApplicableCompletedPrimary

Safety and Efficacy of Selective Intra-Arterial Cooling Infusion Combined With EVT in Acute Ischemic Stroke

Scroll to load more

Research Network

Activity Timeline